Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 12 of 23
Immutrin
Immutrin
CIC Fund II
UK
Active
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2025
Hold
1yr
InCephalo
InCephalo
HTGF IV
Switzerland
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Indapta Therapeutics
Indapta Therapeutics
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Insilico Medicine
Insilico Medicine
Warburg Pincus Asia Real Estate Fund, L.P.
France
Active
Sector
Biotech
InvestorWarburg Pincus
Entry
–
InSphero
InSphero
ZEISS Ventures CVC
Switzerland
Active
Sector
Biotech
InvestorZEISS Ventures
Entry
2023
Hold
3yr
Intercus GmbH
Intercus GmbH
MFT Mittelstands-Fonds Thueringen (MFT)
Germany
Active
Sector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2018
Hold
8yr
Invitris
Invitris
10x Founders Fund I
Germany
Active
Sector
Biotech
Investor10x Founders
Entry
2023
Hold
3yr
Invizius
Invizius
Old College Capital LP
UK
Active
Sector
Biotech
InvestorOld College Capital
Entry
2019
Hold
7yr
iOnctura
iOnctura
XGEN Venture Life Sciences Fund
Switzerland
Active
Sector
Biotech
InvestorXGen Venture SGR
Entry
2024
Hold
2yr
iosBio
iosBio
Shackleton Ventures (Evergreen)
UK
Active
Sector
Biotech
InvestorShackleton Ventures
Entry
2020
Hold
6yr
Isarna
Isarna
S-Refit AG
Germany
Active
Sector
Biotech
InvestorSobera Capital
Entry
2016
Hold
10yr
Isarna Therapeutics
Isarna Therapeutics
MIG Fonds 5
Germany
Active
Sector
Biotech
InvestorMIG Capital
Entry
2005
Hold
21yr
Isavy Biotech
Isavy Biotech
Generations powered by EDHEC
France
Active
Sector
Biotech
InvestorRing Capital
Entry
–
Iteria Biopharma, S.L.
Iteria Biopharma, S.L.
SODIGA Galicia
Spain
Active
Sector
Biotech
InvestorXesGalicia
Entry
2026
Hold
0yr
Jurata Thin Film
Jurata Thin Film
Columbus Life Sciences Fund IV
United States
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2022
Hold
4yr
Juvena Therapeutics
Juvena Therapeutics
Mubadala Capital Other Investments
USA
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Kamau Therapeutics
Kamau Therapeutics
Neva II
United States
Active
Sector
Biotech
InvestorNeva SGR
Entry
2024
Hold
2yr
Kano Therapeutics
Kano Therapeutics
Vsquared Ventures II
United States
Active
Sector
Biotech
InvestorVsquared Ventures
Entry
2024
Hold
2yr
KCAS
KCAS
Vitruvian Investment Partnership IV
United States
Active
Sector
Biotech
InvestorVitruvian Partners
Entry
2021
Hold
5yr
Khloris Biosciences
Khloris Biosciences
Leaps by Bayer
United States
Active
Sector
Biotech
InvestorLeaps by Bayer
Entry
2019
Hold
7yr
Kiji Therapeutics
Kiji Therapeutics
AFB Fund II
France
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2023
Hold
3yr
Kither Biotech
Kither Biotech
Claris Biotech I
Italy
Active
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2022
Hold
4yr
KLISBio
KLISBio
Principia III - Health
Italy
Active
Sector
Biotech
InvestorPrincipia SGR
Entry
2016
Hold
10yr
Kula Bio
Kula Bio
AgFunder Fund IV
United States
Active
Sector
Biotech
InvestorAgFunder
Entry
–
Kupando GmbH
Kupando GmbH
Fruehphasen- und Wachstumsfonds Brandenburg
Germany
Active
Sector
Biotech
InvestorBrandenburg Kapital
Entry
2022
Hold
4yr
LabGenius
LabGenius
Backed Fund I
UK
Active
Sector
Biotech
InvestorBACKED VC
Entry
2017
Hold
9yr
Laigo Bio
Laigo Bio
Angelini Ventures
France
Active
Sector
Biotech
InvestorAngelini Ventures
Entry
2025
Hold
1yr
Launch Therapeutics
Launch Therapeutics
Abingworth Clinical Co-Development Fund 2
US
Active
Sector
Biotech
InvestorAbingworth
Entry
2022
Hold
4yr
Lepure Biotech
Lepure Biotech
General Atlantic Portfolio
United States
Active
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Leukos Biotech
Leukos Biotech
Inveready Biotech II
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
10yr
Libera Bio, S.L.
Libera Bio, S.L.
SODIGA Galicia
Spain
Active
Sector
Biotech
InvestorXesGalicia
Entry
2022
Hold
4yr
Libera Biotech
Libera Biotech
Scientifica S.p.A. (Balance Sheet)
Italy
Active
Sector
Biotech
InvestorScientifica Venture Capital
Entry
2022
Hold
4yr
Longevity Biotech
Longevity Biotech
EMV Capital Evergreen Fund
United States
Active
Sector
Biotech
InvestorEMV Capital
Entry
2014
Hold
12yr
Loop Dee Science
Loop Dee Science
GOCA3
France
Active
Sector
Biotech
InvestorGo Capital
Entry
2023
Hold
3yr
LoQus23 Therapeutics
LoQus23 Therapeutics
Dementia Discovery Fund
UK
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2019
Hold
7yr
LUCA Science
LUCA Science
4BIO Ventures III
Japan
Active
Sector
Biotech
Investor4Bio Partners
Entry
2022
Hold
4yr
Macomics
Macomics
Old College Capital LP
UK
Active
Sector
Biotech
InvestorOld College Capital
Entry
2020
Hold
6yr
March Biosciences
March Biosciences
4BIO Ventures III
US
Active
Sector
Biotech
Investor4Bio Partners
Entry
2024
Hold
2yr
MatchBio
MatchBio
Oxford Science Enterprises Balance Sheet
UK
Active
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2024
Hold
2yr
MEDEA Biopharma
MEDEA Biopharma
Caesar Ventures Fund I
Germany
Active
Sector
Biotech
InvestorCaesar Ventures Management
Entry
2024
Hold
2yr
Medinect Bioservices Ltd
Medinect Bioservices Ltd
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2022
Hold
4yr
Meiogenix
Meiogenix
Sofinnova Industrial Biotech
France
Active
Sector
Biotech
InvestorSofinnova Partners
Entry
2019
Hold
7yr
Mereo BioPharma
Mereo BioPharma
Rosetta Capital V
UK
Active
Sector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Mesenbio
Mesenbio
DSW Ventures
UK
Active
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Mestag Therapeutics
Mestag Therapeutics
SV7 Impact Medicine Fund
UK
Active
Sector
Biotech
InvestorSV Health Managers
Entry
2021
Hold
5yr
Micthera
Micthera
Indaco BIO
Italy
Active
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2024
Hold
2yr
Mimetic Medicine
Mimetic Medicine
AgFunder Fund IV
USA
Active
Sector
Biotech
InvestorAgFunder
Entry
–
Mimetic Medicines
Mimetic Medicines
AgFunder Fund IV
United States
Active
Sector
Biotech
InvestorAgFunder
Entry
–
Minoryx
Minoryx
Inveready Biotech I
France
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2013
Hold
13yr
Modern Meadow
Modern Meadow
Evonik Venture Capital
United States
Active
Sector
Biotech
InvestorEvonik Venture Capital
Entry
2019
Hold
7yr